NeuroCytonix Inc.
Edit

NeuroCytonix Inc.

https://www.neurocytonix.com/
Last activity: 03.07.2024
Active
Categories: BioTechInformationMedtechResearchTechnology
NeuroCytonix Inc, is an emerging biotechnology company founded in January 2017 to develop and exploit disruptive medical technologies for regeneration of the nervous system. NEUROCYTONIX has developed a new technology that we have found to be effective in treating patients suffering from Cerebral Palsy, Stroke, Traumatic Brain Injury(TBI) related neurological consequences and Covid 19 neurological issues in brief non degenerative brain diseases. Please see www.neurocytonix.com for more information on our company based in Rockville MD.
Followers
211
Mentions
5
Location: United States, Maryland, Rockville
Employees: 11-50
Total raised: $4M
Founded date: 2017

Funding Rounds 1

DateSeriesAmountInvestors
09.04.2023-$4M-

Mentions in press and media 5

DateTitleDescription
03.07.2024NeuroCytonix Launches Clinical Trial Studying Its NeuroCytotron Protocol for AutismWe explore innovative solutions to repair the brain and cure the incurable. The NeuroCytotron utilizes non-invasive, safe tissue engineering technology to stimulate proteins that aid in the regeneration of brain cells. ROCKVILLE, Md., July ...
02.03.2023NeuroCytonix Bahamas Ltd. Announces $12 Million Capital RaiseNeuroCytonix Bahamas Ltd. Announces $12 Million Capital Raise: NeuroCytonix’s technology has shown to be effective in treating patients suffering from incurable neurological disorders NASSAU, Bahamas (PRWEB) March 02, 2023 NeuroCytonix, Bah...
30.01.2023NeuroCytonix Completes Clinical Trial of its NeuroCytotron Treatment of Cerebral PalsyNeuroCytonix Logo NeuroCytonix Completes Clinical Trial of its NeuroCytotron Treatment of Cerebral Palsy ROCKVILLE, Md. (PRWEB) January 30, 2023 NeuroCytonix, Inc. (the “Company” or “NeuroCytonix”) today announced that on January 19, 2023, ...
24.03.2022NeuroCytonix Board of Directors Appoints Jeff Balagna as Vice ChairmanROCKVILLE, Md. (PRWEB) March 24, 2022 NeuroCytonix Inc., today announced that Jeff Balagna, a Partner at Gryphon Investors, LLC, has been appointed as a Vice Chairman of their Board of Directors. As NeuroCytonix’s Vice Chairman of the Board...
-NeuroCytonix“Home | NeuroCytonix”

Reviews 0

Sign up to leave a review

Sign up Log In